Advertisement
Section edited by Carlo Lombardi
Review
Recently, some studies demonstrated that HMGB1, as proinflammatory mediator belonging to the alarmin family, has a key role in different acute and chronic immune disorders. Asthma is a complex disease characte...
Clinical and Molecular Allergy 2017 15:12
Published on: 14 June 2017
Research
In Europe more than 50% of asthmatic treated patients have not well-controlled asthma. Asthma affects about 2.5 million of patients in Italy.
Clinical and Molecular Allergy 2017 15:11
Published on: 8 May 2017
Commentary
Even if severe asthma (SA) accounts for 5–10% of all cases of the disease, it is currently a crucial unmet need, owing its difficult clinical management and its high social costs. For this reason several netwo...
Clinical and Molecular Allergy 2017 15:9
Published on: 10 April 2017
Review
This meta-analysis compared the health-related quality of life (HRQL) of patients with allergic rhinitis (AR) and/or allergic asthma (AA) caused by perennial house dust mite (HDM) versus AR and/or AA caused by...
Clinical and Molecular Allergy 2016 14:12
Published on: 28 September 2016
Commentary
In a historical period in which sustainability of the National Health Service is mandatory because of the international economical situation, the limited available resources at national level and the tendency ...
Clinical and Molecular Allergy 2016 14:5
Published on: 19 April 2016
Research
Published data suggest that asthma is significantly under/misdiagnosed. The present community-based study performed in Italy aims at investigating the level of asthma under/misdiagnosis among patients referrin...
Clinical and Molecular Allergy 2015 13:26
Published on: 16 November 2015
Research
General practitioners (GPs), community pharmacists and allergic rhinitis (AR) patients in Italy were surveyed in order to gain insight from all three perspectives into the diagnosis, management and burden of A...
Clinical and Molecular Allergy 2015 13:25
Published on: 2 November 2015
Review
Severe asthma (SA) is a clinically and etiologically heterogeneous respiratory disease which affects among 5–10 % of asthmatic patients. Despite high-dose therapy, a large patients percentage is not fully cont...
Clinical and Molecular Allergy 2015 13:20
Published on: 1 October 2015
Review
Rhinitis is often the first symptom of allergy but is frequently ignored and classified as a nuisance condition. Ironically it has the greatest socioeconomic burden worldwide caused by its impact on work and o...
Clinical and Molecular Allergy 2015 13:17
Published on: 4 August 2015
Review
The prevalence of asthma in the most advanced ages is similar to that of younger ages. However, the concept that older individuals may suffer from allergic asthma has been largely denied in the past, and a com...
Clinical and Molecular Allergy 2015 13:7
Published on: 22 June 2015
Review
Despite the use of antibiotics and vaccines, the frequency of respiratory tract infections is still high and these infections interest a wide range of patients, from children to aged people, including in parti...
Clinical and Molecular Allergy 2015 13:8
Published on: 21 May 2015
Research
In the latest decades, epidemiological studies on allergic disorders in children, including atopic dermatitis, rhinitis and asthma, demonstrated a continuous increase in prevalence. However, such studies are u...
Clinical and Molecular Allergy 2015 13:2
Published on: 7 May 2015
The Erratum to this article has been published in Clinical and Molecular Allergy 2015 13:18
Research
Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) is a common disorder in the general population but often underestimated and underdiagnosed.
Clinical and Molecular Allergy 2015 13:4
Published on: 15 April 2015
The official journal of the Italian Society of Allergology, Asthma and Clinical Immunology (SIAAIC)
Advertisement
